A Single Centric, Open-Label, Non-Randomized Phase IV Post- Marketing Surveillance Study To Evaluate The Efficacy And Safety of Eye Mantra Drop in Subjects Suffering From Conjunctivitis, Iritis, Dry Eyes, Eye Strain, Itchy Eyes, And Watery Eyes.

Divisa Herbals Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1.Male and female subjects aged between 18 to 80 years
•2.Subjects with a clinical diagnosis of either conjunctivitis, Iritis, dry eyes, eye strain, itchy eyes, watery eyes, or tired eyes.
•3.Be willing to discontinue wearing contact lenses for the duration of the study.
•4.Subjects willing to give written informed consent and adhere to all the study procedures.

•1.Females who are pregnant, lactating, or have the potential to bear children.
•2.Subjects with uncontrolled diabetes mellitus, ocular trauma, and corneal complications such as marginal corneal ulcer, trachoma, keratoconjunctivitis, etc.
•3.Have any clinically significant optic nerve defects.
•4.Subjects with a history of recent eye surgery or planning for an eye surgery.
•5.Subjects have already taken part in another clinical study (device or drug) within 30 days prior to screening.
•6.Active users or have used any topical ocular or systemic antibiotics, topical ocular non-steroidal anti-inflammatory drugs, topical ophthalmic or systemic corticosteroids, non-corticosteroid immunosuppressive agents or other medication such as antispasmodic drugs like atropine within <= 30 days of enrolment.
•7.Persistent contact lens users.
•8.Not willing to sign the informed consent form.

发起方

Divisa Herbals Pvt. Ltd.